BARER SOL J

CIK 000124701511 companiesSUMMIT, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001247015

Recent Transactions

50 trades

Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2025-06-06−17,158→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2025-06-06+17,158→ 426,272 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2025-06-05+21,739→ 21,739 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2024-06-15−37,598→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2024-06-15+37,598→ 409,114 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2024-06-06+17,158→ 17,158 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2023-08-04+28,162→ 371,516 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2023-08-04−28,162→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-07-05+44,983→ 44,983 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2023-06-15+37,598→ 37,598 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−61,678→ 0 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−155,900→ 0 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+19,113→ 19,113 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+61,678→ 61,678 total
Award
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04+155,900→ 155,900 total
Disposition to Issuer
NexImmune, Inc.
Stock Option (right to buy)
2023-04-04−19,113→ 0 total
Purchase
NexImmune, Inc.
Common Stock
2023-03-30$0.41/sh+400,000→ 2,217,814 total
Purchase
NexImmune, Inc.
Common Stock
2022-11-17$0.48/sh+75,000→ 1,817,814 total
Purchase
NexImmune, Inc.
Common Stock
2022-11-16$0.48/sh+125,000→ 1,742,814 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2022-08-04+28,162→ 28,162 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2022-06-14−25,791→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2022-06-14+25,791→ 343,354 total
Award
NexImmune, Inc.
Stock Option (Right to Buy)
2022-06-13+61,678→ 61,678 total
Purchase
NexImmune, Inc.
Common Stock
2022-06-02$2.22/sh+20,720→ 1,617,814 total
Purchase
NexImmune, Inc.
Common Stock
2022-06-01$2.35/sh+40,000→ 1,597,094 total
Purchase
NexImmune, Inc.
Common Stock
2022-05-31$2.19/sh+39,280→ 1,557,094 total
Award
CONTRAFECT Corp
Options (Right to Buy)
2022-05-17$3.35/sh+42,000→ 42,000 total
Purchase
NexImmune, Inc.
Common Stock
2022-03-23$2.67/sh+10,000→ 1,517,814 total
Purchase
NexImmune, Inc.
Common Stock
2022-03-22$2.41/sh+30,000→ 1,507,814 total
Purchase
NexImmune, Inc.
Common Stock
2022-03-21$2.14/sh+30,000→ 1,477,814 total
Purchase
NexImmune, Inc.
Common Stock
2022-03-18$2.11/sh+30,000→ 1,447,814 total
Exercise/Conversion
NexImmune, Inc.
Stock Option (right to buy)
2021-12-21−50,000→ 155,900 total
Exercise/Conversion
NexImmune, Inc.
Common Stock
2021-12-21$5.17/sh+50,000→ 1,417,814 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-06-15+40,000→ 40,000 total
Award
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2021-06-14+25,791→ 25,791 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2021-06-09−22,565→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2021-06-09+22,565→ 317,563 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Restricted Share Units
2021-06-05−17,565→ 0 total
Exercise/Conversion
TEVA PHARMACEUTICAL INDUSTRIES LTD$TEVA
Ordinary Shares
2021-06-05+17,565→ 294,998 total
Award
CONTRAFECT Corp
Options (Right to Buy)
2021-05-18+25,000→ 25,000 total
Purchase
NexImmune, Inc.
Common Stock
2021-02-17$17.00/sh+60,000→ 1,538,013 total
Conversion
NexImmune, Inc.
Series A3 Preferred Stock
2021-02-17−82,204→ 0 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+164,408→ 1,058,444 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+337,365→ 1,478,013 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+217,570→ 346,577 total
Conversion
NexImmune, Inc.
Convertible Promissory Note
2021-02-17→ 0 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+800,182→ 1,367,814 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+894,036→ 894,036 total
Conversion
NexImmune, Inc.
Series A Preferred Stock
2021-02-17−800,182→ 0 total
Conversion
NexImmune, Inc.
Common Stock
2021-02-17+82,204→ 1,140,648 total

BARER SOL J

Recent Transactions

Companies

Recent Filings

Address